Navigation Links
Boosting Pharma Sales Force Effectiveness through Streamlined Internal Communications
Date:12/12/2007

CHAPEL HILL, N.C., Dec. 12 /PRNewswire/ -- The success of a pharmaceutical sales force is built on effective communication. Yet ineffective internal communication between sales reps and regional corporate sources are eating into reps' time on the job, according to a new study by benchmarking leader Best Practices, LLC.

Pharma sales reps spend an average of 13.7 hours a week managing internal communication and, of that, 4.4 hours (or 32 percent) are perceived as unnecessary, according to the study. Most of those 4.4 hours is made up of email and cell phone communications and a vast majority of the communications comes from regional and local sources, according to the study. Sales reps estimate they receive more than 150 email and voicemail communications a week from regional sources.

Pharmaceutical companies could increase sales staff productivity by more than 10 percent by eliminating unnecessary internal communications to the field, according to the study. To learn more about this report, Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication, please download a complimentary report excerpt and study overview at http://www3.best-in-class.com/rr890.htm

The research is based on interviews and benchmarking surveys from 10 leading pharmaceutical and biotech companies, including Pfizer, Eli Lilly, Genentech, Johnson & Johnson and Merck. Executives and managers who oversee sales operations can use this study to improve the productivity of their field sales force.

The research findings from this study highlight significant costs of unnecessary communication across a direct sales force as well as the best practices that sales communications functions, district managers, sales reps and IT managers can use to help prevent unnecessary internal communication.

Some of the key topics covered in the report include:

-- Total time spent on internal communication

-- Percentage of unnecessary time spent

-- Costs of unnecessary communication

-- Most effective communication methods

To learn more about this report, including key findings and sample best practices, download a complimentary excerpt at: http://www3.best-in- class.com/rr890.htm .

For questions or additional information on Best Practices, LLC's other products and services, please call Cameron Tew at 919-767-9246 or email ctew@best-in-class.com. Also, visit our Web site at: http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call 919-403-0251 or visit http://www3.best-in-class.com/.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Schools Getting Better at Boosting Kids Health
2. Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
3. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
4. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
10. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
11. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and delivered ... order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige Delivery ... only 15 miles away from Flint. , “We have deep roots in the local ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Wickman ... created to assist the local community. Pledging to select a new beneficiary every ... in the area. Their goal is to bring community awareness to important local ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 Mylan N.V. (NASDAQ, TASE: MYL) today ... ended December 31, 2015. --> ... total revenues of $9.45 billion, up 28% on a ... revenues of $9.43 billion. Excluding the impact of the ... branded generics business (the "EPD Business"), full year adjusted ...
(Date:2/10/2016)... 10, 2016 CSI Specialty Group (CSI) expanded ... of the Specialty Pharmacy Podcast. A free, weekly show, ... providing real-world education, discussion and context amongst specialty pharmacy ... --> The Specialty Pharmacy Podcast, hosted ... Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is available ...
(Date:2/10/2016)... , Feb. 10, 2016 Urologix, the ... the treatment of Benign Prostatic Hyperplasia (BPH), announces new ... Ash Keswani , a medical device industry veteran of ... the Limited Liability Company.  Plymouth, ... service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, will ...
Breaking Medicine Technology: